Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Strata Skin Sciences Debt to Equity Ratio 2010-2024 | SSKN

Current and historical debt to equity ratio values for Strata Skin Sciences (SSKN) over the last 10 years. The debt/equity ratio can be defined as a measure of a company's financial leverage calculated by dividing its long-term debt by stockholders' equity. Strata Skin Sciences debt/equity for the three months ending September 30, 2024 was 1.62.
  
Strata Skin Sciences Debt/Equity Ratio Historical Data
Date Long Term Debt Shareholder's Equity Debt to Equity Ratio
2024-09-30 $0.03B $0.01B 3.30
2024-06-30 $0.03B $0.01B 3.17
2024-03-31 $0.03B $0.01B 3.25
2023-12-31 $0.03B $0.01B 2.31
2023-09-30 $0.03B $0.02B 1.91
2023-06-30 $0.04B $0.02B 2.27
2023-03-31 $0.03B $0.02B 1.54
2022-12-31 $0.03B $0.02B 1.39
2022-09-30 $0.03B $0.02B 1.44
2022-06-30 $0.03B $0.02B 1.40
2022-03-31 $0.03B $0.02B 1.32
2021-12-31 $0.02B $0.03B 0.83
2021-09-30 $0.02B $0.03B 0.79
2021-06-30 $0.02B $0.03B 0.74
2021-03-31 $0.02B $0.02B 0.90
2020-12-31 $0.02B $0.03B 0.81
2020-09-30 $0.02B $0.03B 0.82
2020-06-30 $0.02B $0.03B 0.73
2020-03-31 $0.02B $0.03B 0.64
2019-12-31 $0.02B $0.03B 0.65
2019-09-30 $0.02B $0.03B 0.65
2019-06-30 $0.02B $0.03B 0.63
2019-03-31 $0.02B $0.03B 0.58
2018-12-31 $0.02B $0.03B 0.52
2018-09-30 $0.01B $0.03B 0.38
2018-06-30 $0.01B $0.03B 0.37
2018-03-31 $0.02B $0.02B 0.86
2017-12-31 $0.02B $0.02B 0.97
2017-09-30 $0.02B $0.02B 0.67
2017-06-30 $0.03B $0.01B 2.69
2017-03-31 $0.03B $0.01B 2.43
2016-12-31 $0.03B $0.02B 1.94
2016-09-30 $0.03B $0.02B 1.71
2016-06-30 $0.03B $0.02B 1.57
2016-03-31 $0.03B $0.02B 2.16
2015-12-31 $0.03B $0.02B 2.11
2015-09-30 $0.04B $0.02B 2.29
2015-06-30 $0.03B $0.03B 1.00
2015-03-31 $0.01B $0.01B 1.15
2014-12-31 $0.01B $0.01B 0.64
2014-09-30 $0.01B $0.02B 0.60
2014-06-30 $0.01B $0.01B 0.75
2014-03-31 $0.01B $0.01B 1.73
2013-12-31 $0.01B $0.01B 0.70
2013-09-30 $0.00B $0.01B 0.28
2013-06-30 $0.01B $0.02B 0.52
2013-03-31 $0.01B $0.02B 0.36
2012-12-31 $0.00B $0.01B 0.24
2012-09-30 $0.00B $0.02B 0.15
2012-06-30 $0.00B $0.02B 0.13
2012-03-31 $0.00B $0.02B 0.07
2011-12-31 $0.00B $0.03B 0.05
2011-09-30 $0.00B $0.02B 0.08
2011-06-30 $0.00B $0.02B 0.06
2011-03-31 $0.00B $0.03B 0.07
2010-12-31 $0.00B $0.03B 0.06
2010-09-30 $0.00B $0.04B 0.05
2010-06-30 $0.00B $0.03B 0.07
2010-03-31 $0.00B $0.03B 0.05
2009-12-31 $0.00B $0.03B 0.06
2009-09-30 $0.00B $0.03B 0.06
2009-06-30 $0.00B $0.01B 0.18
2009-03-31 $0.00B $0.01B 0.13
Sector Industry Market Cap Revenue
Medical Medical Information Systems $0.011B $0.033B
Strata Skin Sciences, Inc. is a medical technology company which focused on the dermatology market. Its products include the XTRAC laser(R) and VTRAC(R) excimer lamp systems for treatment of psoriasis, vitiligo and other skin conditions as well as the MelaFind (R) system used for identification and management of melanoma skin cancer. Strata Skin Sciences, Inc., formerly known as MELA Sciences, Inc., is based in Horsham, Pennsylvania.
Stock Name Country Market Cap PE Ratio
Veeva Systems (VEEV) United States $38.872B 57.28
Tempus AI (TEM) United States $10.232B 0.00
Hims & Hers Health (HIMS) United States $8.842B 224.83
Inspire Medical Systems (INSP) United States $5.430B 169.35
IRhythm Technologies (IRTC) United States $3.397B 0.00
Privia Health (PRVA) United States $2.723B 226.90
Enovis (ENOV) United States $2.544B 16.95
Azenta (AZTA) United States $2.469B 114.98
Clover Health Investments (CLOV) United States $2.225B 0.00
Schrodinger (SDGR) United States $1.886B 0.00
Omnicell (OMCL) United States $1.826B 39.83
10x Genomics (TXG) United States $1.773B 0.00
Phreesia (PHR) United States $1.680B 0.00
Butterfly Network (BFLY) United States $0.937B 0.00
Talkspace (TALK) United States $0.608B 0.00
Standard BioTools (LAB) United States $0.529B 0.00
Fulgent Genetics (FLGT) United States $0.507B 0.00
TruBridge (TBRG) United States $0.380B 110.57
Nyxoah SA (NYXH) Belgium $0.369B 0.00
Health Catalyst (HCAT) United States $0.334B 0.00
Pulmonx (LUNG) United States $0.254B 0.00
SOPHiA GENETICS SA (SOPH) Switzerland $0.233B 0.00
American Well (AMWL) United States $0.176B 0.00
EUDA Health Holdings (EUDA) Singapore $0.104B 0.00
MDxHealth SA (MDXH) Belgium $0.087B 0.00
P3 Health Partners (PIII) United States $0.073B 0.00
CareCloud (CCLD) United States $0.066B 0.00
HeartBeam (BEAT) United States $0.065B 0.00
111 (YI) China $0.057B 0.00
Zepp Health (ZEPP) China $0.045B 0.00
Outset Medical (OM) United States $0.043B 0.00
SHL Telemedicine (SHLT) Israel $0.043B 0.00
Zhongchao (ZCMD) China $0.037B 0.00
Movano (MOVE) United States $0.035B 0.00
Bullfrog AI Holdings (BFRG) United States $0.022B 0.00
MSP Recovery (MSPR) United States $0.019B 0.00
Streamline Health Solutions (STRM) United States $0.016B 0.00
ImmunoPrecise Antibodies (IPA) Canada $0.016B 0.00
Precipio (PRPO) United States $0.010B 0.00
Predictive Oncology (POAI) United States $0.010B 0.00
Mobile-health Network Solutions (MNDR) Singapore $0.006B 0.00
Syra Health (SYRA) United States $0.005B 0.00
Healthcare Triangle (HCTI) United States $0.004B 0.00
HeartSciences (HSCS) United States $0.004B 0.00
Tivic Health Systems (TIVC) United States $0.002B 0.00
Future Health ESG (FHLT) United States $0.000B 0.00